RecruitingNCT06308354
Colorectal Cancer Dataset in Xijing Hospital From 2011
Sponsor
Xijing Hospital
Enrollment
40,000 participants
Start Date
Jan 1, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Plain Language Summary
Simplified for easier understanding
This is a data registry study collecting detailed medical information from colorectal cancer patients treated at Xijing Hospital between 2013 and 2023. It is not a treatment trial — researchers are building a dataset to better understand colorectal cancer patterns and outcomes.
**You may be eligible if...**
- You have been diagnosed with colorectal adenocarcinoma (the most common type of colon/rectal cancer), including hereditary forms like Lynch syndrome or familial polyposis
- You were diagnosed between 2013 and 2023
- You were treated at Xijing Hospital with complete medical and pathology records
**You may NOT be eligible if...**
- Your colorectal cancer is a non-adenocarcinoma type
- Your cancer spread to the colon or rectum from a nearby or distant organ
- You have a benign (non-cancerous) colorectal condition
- Your cancer has returned after previous treatment
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06308354
Related Trials
Measuring Fluid Buildup in Cancer Patients
NCT074436181 location
A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer
NCT075624901 location
Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer
NCT075627111 location
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT0488992460 locations
A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer
NCT072394661 location